PACS Group (NYSE:PACS) Now Covered by Analysts at Oppenheimer

Research analysts at Oppenheimer started coverage on shares of PACS Group (NYSE:PACS) in a report released on Monday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $31.00 price target on the stock. Oppenheimer’s price target would suggest a potential upside of 24.05% from the company’s previous close.

Several other research analysts have also commented on the stock. Truist Financial initiated coverage on shares of PACS Group in a report on Monday. They issued a “buy” rating and a $32.00 price target on the stock. Royal Bank of Canada initiated coverage on shares of PACS Group in a report on Monday. They issued an “outperform” rating and a $30.00 price target on the stock. Six analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $30.50.

PACS Group Trading Up 0.2 %

NYSE PACS opened at $24.99 on Monday. PACS Group has a one year low of $22.61 and a one year high of $25.72.

Insider Buying and Selling

In other PACS Group news, CEO Jason Hulse Murray sold 1,607,142 shares of PACS Group stock in a transaction that occurred on Monday, April 15th. The stock was sold at an average price of $21.00, for a total transaction of $33,749,982.00. Following the sale, the chief executive officer now directly owns 62,754,551 shares in the company, valued at approximately $1,317,845,571. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.